Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Cell Metab ; 33(7): 1358-1371.e5, 2021 07 06.
Article in English | MEDLINE | ID: mdl-33989521

ABSTRACT

Both genetic predisposition and environmental factors appear to play a role in inflammatory bowel disease (IBD) development. Genetic studies in humans have linked the interleukin (IL)-23 signaling pathway with IBD, but the environmental factors contributing to disease have remained elusive. Here, we show that the azo dyes Red 40 and Yellow 6, the most abundant food colorants in the world, can trigger an IBD-like colitis in mice conditionally expressing IL-23, or in two additional animal models in which IL-23 expression was augmented. Increased IL-23 expression led to generation of activated CD4+ T cells that expressed interferon-γ and transferred disease to mice exposed to Red 40. Colitis induction was dependent on the commensal microbiota promoting the azo reduction of Red 40 and generation of a metabolite, 1-amino-2-naphthol-6-sulfonate sodium salt. Together these findings suggest that specific food colorants represent novel risk factors for development of colitis in mice with increased IL-23 signaling.


Subject(s)
Bacteria/metabolism , Colitis , Food Coloring Agents/metabolism , Interleukin-23/genetics , Intestinal Mucosa/microbiology , Animals , Colitis/genetics , Colitis/metabolism , Colitis/microbiology , Disease Models, Animal , Food Coloring Agents/adverse effects , Genetic Predisposition to Disease , Homeodomain Proteins/genetics , Inflammatory Bowel Diseases/genetics , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/microbiology , Interferon-gamma/genetics , Interleukin-23/metabolism , Intestinal Mucosa/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Symbiosis
2.
Nat Rev Immunol ; 20(6): 350, 2020 06.
Article in English | MEDLINE | ID: mdl-32286538
3.
Nat Commun ; 10(1): 4517, 2019 10 04.
Article in English | MEDLINE | ID: mdl-31586069

ABSTRACT

Neonatal inflammatory diseases are associated with severe morbidity, but the inflammatory factors underlying them and their potential effector mechanisms are poorly defined. Here we show that necrotizing enterocolitis in neonate mice is accompanied by elevation of IL-23 and IL-22 and decreased production of pancreatic enzymes. These phenotypes are mirrored in neonate mice overexpressing IL-23 in CX3CR1+ myeloid cells or in keratinocytes. The mice fail to grow and die prematurely, displaying systemic inflammation, nutrient malabsorption and decreased expression of intestinal and pancreatic genes mediating digestion and absorption of carbohydrates, proteins, and lipids. Germ-free environment improves, and genetic ablation of IL-22 restores normal growth in mice overexpressing IL-23. Mechanistically, IL-22 acts directly at the level of pancreatic acinar cells to decrease expression of the pancreas associated transcription factor 1a (PTF1a). These results show that augmented production of IL-23 and IL-22 in early life has a negative impact on pancreatic enzyme secretion and food absorption.


Subject(s)
Enterocolitis, Necrotizing/immunology , Interleukin-23/metabolism , Interleukins/metabolism , Pancreas/enzymology , Transcription Factors/metabolism , Acinar Cells/enzymology , Animals , Animals, Newborn , Cells, Cultured , Disease Models, Animal , Enterocolitis, Necrotizing/pathology , Humans , Interleukin-23/genetics , Interleukin-23/immunology , Interleukins/genetics , Interleukins/immunology , Intestinal Absorption/immunology , Intestinal Mucosa/immunology , Intestinal Mucosa/pathology , Keratinocytes , Mice , Mice, Knockout , Myeloid Cells , Pancreas/cytology , Primary Cell Culture , Interleukin-22
4.
Gastroenterology ; 157(6): 1572-1583.e8, 2019 12.
Article in English | MEDLINE | ID: mdl-31470007

ABSTRACT

BACKGROUND & AIMS: Transgenic mice (HBUS) that express the epidermal growth factor receptor (EGFR) ligand HBEGF (heparin-binding epidermal growth factor-like growth factor) and a constitutively active G protein-coupled receptor (US28) in intestinal epithelial cells develop serrated polyps in the cecum. Development of serrated polyps depends on the composition of the gut microbiota and is associated with bacterial invasion of the lamina propria, accompanied by induction of inflammation and up-regulation of interleukin 1 beta (IL1B) and matrix metalloproteinase (MMP) 3 in the cecum. We investigated the mechanisms by which these changes contribute to development of serrated polyps. METHODS: We performed studies with C57BL/6 (control) and HBUS mice. To accelerate polyp development, we increased the exposure of the bacteria to the lamina propria by injecting HBUS mice with diphtheria toxin, which binds transgenic HBEGF expressed by the epithelial cells and causes apoptosis. Mice were given injections of IL1B-neutralizing antibody and the MMP inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycyl hydroxamic acid. Intestinal tissues were collected from mice and analyzed by histology, reverse-transcription polymerase chain reaction, enzyme-linked immunosorbent assay, immunofluorescence, and flow cytometry. We examined fibroblast subsets in polyps using single-cell RNA sequencing. RESULTS: Administration of diphtheria toxin to HBUS mice accelerated development of serrated polyps (95% of treated mice developed polyps before 100 days of age, compared with 53% given vehicle). IL1B stimulated subsets of platelet-derived growth factor receptor alpha+ (PDGRFA+) fibroblasts isolated from cecum, resulting in increased expression of MMP3. Neutralizing antibodies against IL1B or administration of the MMP inhibitor reduced the number of serrated polyps that formed in the HBUS mice. Single-cell RNA sequencing analysis showed subsets of fibroblasts in serrated polyps that express genes that regulate matrix fibroblasts and inflammation. CONCLUSIONS: In studies of mice, we found that barrier breakdown and expression of inflammatory factors contribute to development of serrated polyps. Subsets of cecal PDGFRA+ fibroblasts are activated by release of IL1B from myeloid cells during the early stages of serrated polyp development. MMP3 produced by PDGFRA+ fibroblasts is important for serrated polyp development. Our findings confirm the functions of previously identified serrated polyp-associated molecules and indicate roles for immune and stromal cells in serrated polyp development.


Subject(s)
Colonic Polyps/immunology , ErbB Receptors/metabolism , Interleukin-1beta/metabolism , Intestinal Mucosa/pathology , Matrix Metalloproteinase 3/metabolism , Animals , Apoptosis/immunology , Cecum/cytology , Cecum/immunology , Cecum/pathology , Diphtheria Toxin/administration & dosage , Diphtheria Toxin/immunology , Disease Models, Animal , Epithelial Cells/immunology , Epithelial Cells/pathology , ErbB Receptors/antagonists & inhibitors , Fibroblasts/immunology , Fibroblasts/metabolism , Gefitinib/pharmacology , Heparin-binding EGF-like Growth Factor/genetics , Heparin-binding EGF-like Growth Factor/metabolism , Humans , Hydroxamic Acids/pharmacology , Interleukin-1beta/immunology , Intestinal Mucosa/cytology , Intestinal Mucosa/immunology , Matrix Metalloproteinase 3/immunology , Matrix Metalloproteinase Inhibitors/pharmacology , Mice , Mice, Transgenic , Receptor, Platelet-Derived Growth Factor alpha/metabolism , Sulfonamides/pharmacology
5.
J Leukoc Biol ; 105(5): 1027-1039, 2019 05.
Article in English | MEDLINE | ID: mdl-30860634

ABSTRACT

CXCL17 is a homeostatic chemokine in the mucosa known to chemoattract dendritic cells and macrophages but can also be expressed elsewhere under inflammatory conditions. Cxcl17-/- mice have lower numbers of macrophages or dendritic cells in mucosal tissues. CXCL17 is also able to chemoattract suppressor myeloid cells that can recruit regulatory T cells. To explore a possible role of Cxcl17 in T cells, we studied T cell populations from Cxcl17-/- or wild-type (WT) littermate mice. Cxcl17-/- mice have higher numbers of CD4+ and CD8+ T cells in spleen and lymph nodes (LNs). Upon activation, they produce higher levels of several proinflammatory cytokines and chemokines. Furthermore, a Cxcl17-/- mouse developed exacerbated disease in a T cell-dependent model of experimental autoimmune encephalomyelitis (EAE). By 18 days after immunization with myelin oligodendrocyte peptide, only 44% of Cxcl17-/- mice were still alive vs. 90% for WT mice. During EAE, Cxcl17-/- mice exhibited higher numbers of lymphoid and myeloid cells in spleen and LNs, whereas they had less myeloid cell infiltration in the CNS. Cxcl17-/- mice also had higher levels of some inflammatory cytokines in serum, suggesting that they may be involved in the poor survival of these mice. Abnormal T cell function may reflect altered myeloid cell migration, or it could be due to altered T cell development in the thymus. We conclude that CXCL17 is a novel factor regulating T cell homeostasis and function.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Chemokines, CXC/genetics , Encephalomyelitis, Autoimmune, Experimental/genetics , Myeloid Cells/immunology , Animals , Antigens, CD/genetics , Antigens, CD/immunology , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/pathology , Cell Movement/immunology , Central Nervous System/immunology , Central Nervous System/pathology , Chemokines, CXC/deficiency , Chemokines, CXC/immunology , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Gene Expression Regulation , Homeostasis/immunology , Immunoglobulins/genetics , Immunoglobulins/immunology , Lymph Nodes/immunology , Lymph Nodes/pathology , Lymphocyte Activation , Mice , Mice, Knockout , Myelin-Oligodendrocyte Glycoprotein/administration & dosage , Myeloid Cells/pathology , Peptide Fragments/administration & dosage , Primary Cell Culture , Spleen/immunology , Spleen/pathology , Survival Analysis , Thymus Gland/immunology , Thymus Gland/pathology
6.
J Interferon Cytokine Res ; 39(4): 214-223, 2019 04.
Article in English | MEDLINE | ID: mdl-30855201

ABSTRACT

CCL28 is a mucosal chemokine that has been involved in various responses, including IgA production. We have analyzed its production in human tissues using a comprehensive microarray database. Its highest expression is in the salivary gland, indicating that it is an important component of saliva. It is also expressed in the trachea, bronchus, and in the mammary gland upon onset of lactation. We have also characterized a Ccl28-/- mouse that exhibits very low IgA levels in milk, and the IgA levels in feces are also reduced. These observations confirm a role for the CCL28/CCR10 chemokine axis in the recruitment of IgA plasmablasts to the lactating mammary gland. CCL28 is also expressed in the vomeronasal organ. We also detected olfactory defects (anosmia) in a Ccl28-/- mouse suggesting that CCL28 is involved in the function/development of olfaction. Importantly, Ccl28-/- mice are highly susceptible to Salmonella enterica serovar Typhimurium in an acute model of infection, indicating that CCL28 plays a major role in innate immunity against Salmonella in the gut. Finally, microbiome studies revealed modest differences in the gut microbiota between Ccl28-/- mice and their cohoused wild-type littermates. The latter observation suggests that under homeostatic conditions, CCL28 plays a limited role in shaping the gut microbiome.


Subject(s)
Chemokines, CC/immunology , Chemokines, CC/physiology , Immunity, Innate/immunology , Immunity, Mucosal/immunology , Immunoglobulin A/immunology , Salmonella Infections, Animal/immunology , Smell/physiology , Adaptive Immunity/immunology , Animals , Gastrointestinal Microbiome/immunology , Homeostasis/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Salmonella Infections, Animal/microbiology , Salmonella enterica/immunology
7.
J Immunol ; 201(12): 3669-3676, 2018 12 15.
Article in English | MEDLINE | ID: mdl-30464051

ABSTRACT

We have described a novel cytokine encoded by a gene called Meteorin-like (Metrnl). Metrnl is a small (∼28 kDa) secreted protein expressed by activated macrophages and barrier tissues (mucosa and skin). Metrnl production by bone marrow macrophages is induced by several cytokines including TNF-α, IL-17α, IL-12, and IL-4 and inhibited by IFN-γ and TGF-ß. Metrnl expression in macrophages is also induced by LPS, and its levels in circulation are associated with inflammatory responses in vivo. Furthermore, Metrnl regulates the production of several cytokines and chemokines in macrophages. We have produced a Metrnl-/- mouse, which is viable and shows normal development. However, it exhibits dysregulated cytokine production, alterations in IgG production, and is highly susceptible to LPS in a sepsis model. Furthermore, older Metrnl-/- mice develop inflammatory lesions, suggesting that Metrnl participates in the control of inflammatory responses. Taken together, these observations indicate that Metrnl encodes a novel immunoregulatory cytokine associated with inflammatory responses that we have designated Meteorin-ß.


Subject(s)
Inflammation/immunology , Macrophages/physiology , Mucous Membrane/metabolism , Nerve Growth Factors/metabolism , Sepsis/immunology , Skin/metabolism , Animals , Cytokines/metabolism , Disease Models, Animal , Humans , Immunomodulation , Lipopolysaccharides/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Nerve Growth Factors/genetics
8.
J Interferon Cytokine Res ; 38(10): 423-439, 2018 10.
Article in English | MEDLINE | ID: mdl-30328794

ABSTRACT

Cytokines are important molecules that regulate the ontogeny and function of the immune system. They are small secreted proteins usually produced upon activation of cells of the immune system, including lymphocytes and myeloid cells. Many cytokines have been described, and several have been recognized as pivotal players in immune responses and in human disease. In fact, several anticytokine antibodies have proven effective therapeutics, especially in various autoimmune diseases. In the last 15 years, new cytokines have been described, and many remain poorly understood. Among the most recent cytokines discovered are interleukins-30 (IL-30) to IL-40. Several of these are members of other cytokine superfamilies, including several IL-1 superfamily members (IL-33, IL-36, IL-37, and IL-38) as well as several new members of the IL-12 family (IL-30, IL-35, and IL-39). The rest (IL-31, IL-32, IL-34, and IL-40) are encoded by genes that do not belong to any cytokine superfamily. Our aim of this review was to present a concise version of the information available on these novel cytokines to facilitate their understanding by members of the immunological community.


Subject(s)
Interleukins/immunology , Animals , Humans
9.
J Immunol ; 199(9): 3326-3335, 2017 11 01.
Article in English | MEDLINE | ID: mdl-28978694

ABSTRACT

We describe a novel B cell-associated cytokine, encoded by an uncharacterized gene (C17orf99; chromosome 17 open reading frame 99), that is expressed in bone marrow and fetal liver and whose expression is also induced in peripheral B cells upon activation. C17orf99 is only present in mammalian genomes, and it encodes a small (∼27-kDa) secreted protein unrelated to other cytokine families, suggesting a function in mammalian immune responses. Accordingly, C17orf99 expression is induced in the mammary gland upon the onset of lactation, and a C17orf99-/- mouse exhibits reduced levels of IgA in the serum, gut, feces, and lactating mammary gland. C17orf99-/- mice have smaller and fewer Peyer's patches and lower numbers of IgA-secreting cells. The microbiome of C17orf99-/- mice exhibits altered composition, likely a consequence of the reduced levels of IgA in the gut. Although naive B cells can express C17orf99 upon activation, their production increases following culture with various cytokines, including IL-4 and TGF-ß1, suggesting that differentiation can result in the expansion of C17orf99-producing B cells during some immune responses. Taken together, these observations indicate that C17orf99 encodes a novel B cell-associated cytokine, which we have called IL-40, that plays an important role in humoral immune responses and may also play a role in B cell development. Importantly, IL-40 is also expressed by human activated B cells and by several human B cell lymphomas. The latter observations suggest that it may play a role in the pathogenesis of certain human diseases.


Subject(s)
B-Lymphocytes/immunology , Gene Expression Regulation/immunology , Interleukins/immunology , Peyer's Patches/immunology , Animals , Humans , Immunoglobulin A/immunology , Interleukins/genetics , Jurkat Cells , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/immunology , Mice , Mice, Knockout
10.
Proc Natl Acad Sci U S A ; 112(47): 14415-22, 2015 Nov 24.
Article in English | MEDLINE | ID: mdl-26489649

ABSTRACT

The long noncoding X-inactivation-specific transcript (Xist gene) is responsible for mammalian X-chromosome dosage compensation between the sexes, the process by which one of the two X chromosomes is inactivated in the female soma. Xist is essential for both the random and imprinted forms of X-chromosome inactivation. In the imprinted form, Xist is paternally marked to be expressed in female embryos. To investigate the mechanism of Xist imprinting, we introduce Xist transgenes (Tg) into the male germ line. Although ectopic high-level Xist expression on autosomes can be compatible with viability, transgenic animals demonstrate reduced fitness, subfertility, defective meiotic pairing, and other germ-cell abnormalities. In the progeny, paternal-specific expression is recapitulated by the 200-kb Xist Tg. However, Xist imprinting occurs efficiently only when it is in an unpaired or unpartnered state during male meiosis. When transmitted from a hemizygous father (+/Tg), the Xist Tg demonstrates paternal-specific expression in the early embryo. When transmitted by a homozygous father (Tg/Tg), the Tg fails to show imprinted expression. Thus, Xist imprinting is directed by sequences within a 200-kb X-linked region, and the hemizygous (unpaired) state of the Xist region promotes its imprinting in the male germ line.


Subject(s)
Genomic Imprinting , Germ Cells/metabolism , RNA, Long Noncoding/genetics , Animals , Blastocyst/metabolism , Epigenesis, Genetic , Female , Hemizygote , Infertility, Male/genetics , Infertility, Male/pathology , Male , Mice, Transgenic , Phenotype , RNA, Long Noncoding/chemical synthesis , RNA, Long Noncoding/metabolism , Transgenes
11.
Cytokine ; 74(2): 318-26, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25742773

ABSTRACT

The adaptive immune system consists of two types of lymphocytes: T and B cells. These two lymphocytes originate from a common precursor, yet are fundamentally different with B cells mediating humoral immunity while T cells mediate cell mediated immunity. In cytokine production, naïve T cells produce multiple cytokines upon activation while naïve activated B cells do not. B cells are capable of producing cytokines, but their cytokine production depends on their differentiation state and activation conditions. Hence, unlike T cells that can produce a large amount of cytokines upon activation, B cells require specific differentiation and activation conditions to produce cytokines. Many cytokines act on B cells as well. Here, we discuss several cytokines and their effects on B cells including: Interleukins, IL-7, IL-4, IL-6, IL-10, and Interferons, IFN-α, IFN-ß, IFN-γ. These cytokines play important roles in the development, survival, differentiation and/or proliferation of B cells. Certain chemokines also play important roles in B cell function, namely antibody production. As an example, we discuss CCL28, a chemokine that directs the migration of plasma cells to mucosal sites. We conclude with a brief overview of B cells as cytokine producers and their likely functional consequences on the immune response.


Subject(s)
Antibody Formation , B-Lymphocytes/immunology , Cellular Microenvironment/immunology , Cytokines/immunology , Lymphocyte Activation , Animals , B-Lymphocytes/pathology , Humans
12.
Fungal Biol ; 118(3): 330-9, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24607357

ABSTRACT

Coccidioidomycosis (Valley Fever) represents a serious threat to inhabitants of endemic areas of North America. Despite successful clinical isolations of the fungal etiological agent, Coccidioides spp., the screening of environmental samples has had low effectiveness, mainly because of the poor characterization of Coccidioides ecological niche. We explored Valle de las Palmas, Baja California, Mexico, a highly endemic area near the U.S.-Mexico border, where we previously detected Coccidioides via culture-independent molecular methods. By testing the serum from 40-trapped rodents with ELISA, we detected antibodies against Coccidioides in two species: Peromyscus maniculatus and Neotoma lepida. This study comprises the first report of wild rodent serum tested for coccidioidal antibodies, and sets the basis to analyze this pathogen in its natural environment and explore its potential ecological niche.


Subject(s)
Antibodies, Fungal/blood , Coccidioides/immunology , Coccidioidomycosis/immunology , Coccidioidomycosis/veterinary , Peromyscus , Sigmodontinae , Animals , Enzyme-Linked Immunosorbent Assay , Mexico , Serum/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...